Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219992 · ClinicalTrials.gov registry record · NA
Parent-Based Treatment for Adolescent Anxiety
A NA study of Anxiety Disorder of Adolescence, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT07219992: Recruiting NA study of Anxiety Disorder of Adolescence, sponsored by Yale University.
NCT07219992 is a NA study of Anxiety Disorder of Adolescence that is actively recruiting participants, run by Yale University. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219992, a NA study of Anxiety Disorder of Adolescence, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.
Primary Outcome
This scale measures anxiety symptoms on 7 dimensions (e.g., avoidance, severity) from 0 ("minimal") to 5 ("extreme"). Total scores range from 0 - 35. Higher scores indicate greater anxiety severity.
Conditions Studied
Interventions
- BEHAVIORAL Supportive Parenting for Anxious Childhood Emotions (SPACE)
- BEHAVIORAL Parent Educational Support (PES)
Study Locations (1)
Connecticut
- Yale Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2028-11 |
| Phase | NA |
What NCT07219992 shows while recruiting
NCT07219992 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Anxiety Disorder of Adolescence appearing as the primary indexed condition, and to 2 interventions - of which Supportive Parenting for Anxious Childhood Emotions (SPACE) is the first listed.
NCT07219992 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07219992 about?
NCT07219992 is a clinical study titled "Parent-Based Treatment for Adolescent Anxiety". This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled t...
What is the current status of trial NCT07219992?
This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-11-01. Estimated completion is 2028-11.
What conditions does trial NCT07219992 study?
This clinical trial studies the following conditions: Anxiety Disorder of Adolescence.
What interventions are being tested in trial NCT07219992?
The interventions under investigation include: Supportive Parenting for Anxious Childhood Emotions (SPACE) (BEHAVIORAL), Parent Educational Support (PES) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219992?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219992 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07219992's enrollment target sits among peer trials
108 825th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI